Pre-Diabetes Type 2 Diabetes Goal Normal Glucose Levels
Pre-Diabetes Type 2 Diabetes Goal Normal Glucose Levels – Emory University researchers say normal glucose levels should be the goal for management of patients with early type 2 diabetes mellitus (T2DM) and pre-diabetes.
In a commentary published online in Nature Reviews Endocrinology, Lawrence S. Phillips, MD, and Darin E. Olson, MD, PhD write that “although T2DM is a major public health problem, few clinicians screen routinely to detect this problem early or manage hyperglycemia (high blood sugar) aggressively if it is found.” They say there is now evidence these practices should change.
The researchers based their statement on several pieces of evidence: A recent report from the Diabetes Prevention Program Outcomes Study (DPPOS) in The Lancet which showed there was less development of T2DM in those patients with pre-diabetes who were able to reduce their blood glucose to normal levels.
“How the normal glucose levels were achieved did not seem to matter,” says Phillips, a professor at the Atlanta VA Medical Center and in the division of endocrinology at Emory University School of Medicine.
“The benefit was comparable if patients used diet and exercise or took a diabetes drug – but there was more benefit if normal glucose was achieved several times compared to just once.”
Additional evidence included observations that T2DM and pre-diabetes adversely impact individuals and the healthcare system; progression from pre-diabetes to T2DM can be prevented or delayed by lifestyle changes or pharmacotherapy; preventing or delaying progression to T2DM is likely to improve important health outcomes; there are plausible biological mechanisms for the benefit to the body’s insulin-producing cells of maintaining normal glucose levels; and targeting normal glucose levels can be undertaken at little risk of harm to patients.
From the combined evidence, the researchers are making three recommendations for clinicians and healthcare systems:
1) Screen to identify patients with early T2DM and high-risk pre-diabetes (fasting glucose ≥110 mg/dl or two‑hour oral glucose tolerance test glucose ≥140 mg/dl). This screening would identify an estimated 22 percent of adults in the United States based on data from the National Health and Nutrition Examination Survey 2005–2006. Screening should be systematic and aimed at patients who are at risk on the basis of age, weight or other characteristics and testing should be repeated, if negative, at a cost-effective frequency – about every three years.
2) Treat high-risk patients aggressively, beginning with an intensive lifestyle intervention (diet and exercise), and intensifying treatment progressively with addition of drug therapy as needed to achieve normal glucose levels.
3) Conduct a randomized, controlled trial in patients with early T2DM and high-risk pre-diabetes to evaluate the benefits, risks and costs of patient management aimed at achieving normal glucose levels.
“The trial we call for is needed to provide optimal evidence, but we believe that the time to begin changing medical practice is now,” says Olson, an assistant professor at the Atlanta VA Medical Center and in the division of endocrinology at Emory University School of Medicine.
Pre-diabetes and T2DM are metabolic disorders that are due to inability of the body’s insulin-producing cells to make enough insulin to keep blood glucose levels in the normal range. Over time, these disorders can lead to blindness, kidney failure, nerve damage, heart attacks and strokes.
Pre-diabetes is a condition that occurs when a person’s blood glucose levels are higher than normal but not high enough for a diagnosis of type 2 diabetes. Many patients with pre-diabetes go on to develop T2DM.
We are in agreement that early and aggressive treatment through diet and lifestyle changes should be the first treatment option for all types of diabetes, including pre-diabetes. It is nice to have drugs available when they are needed for further control to get people closer to the normal glucose levels. However, much can be done through diet and lifestyle changes to move people toward normal blood sugar levels. Unfortunately, the health care system is not set up to pay for these natural approaches so that they can be reinforced and incentivized. That needs to change.
We need to view chronic and autoimmune diseases as conditions of society more than conditions of individuals. We need to treat the societal ill of processed foods, environmental toxins, high stress with inadequate sleep and too little exercise. Until those are addressed on a societal level, the individual stands against the flow of the entire society. It can be done, but it is much more difficult.
If Normal blood sugar levels are a worthy goal for people with pre- and type 2 diabetes, why not type 1 diabetes as well? We think this is a goal worth that can be attained much more easily if diet and lifestyle changes are integrated into your daily living routines.
Until #CuringType1Diabetes is a reality within our reach, put your body in a position of strength to #MasterDiabetes the healthiest way possible. Lifestyle innovations as a priority over drug therapies may be the solution. Poor health feeds poor health in a vicious cycle, or negative feedback loop that is increasingly difficult to break the longer it continues. Promoting, supporting and creating health set in motion a positive feedback loop instead.
Get tools and solutions to help minimize consequences and maximize benefits for nutrition, environment, exercise, sleep and stress management. These five health components make up the five pillars of health and nutrition in the Health-e-Solutions lifestyle. We’ll teach you how to improve each of these areas to help you Master Diabetes the healthiest way possible.